Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division
03 mars 2022 08h00 HE
|
DSS, Inc.
ROCHESTER, N.Y., March 03, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research...
CORRECTION - DSS Announces Letter to Shareholders
28 févr. 2022 17h15 HE
|
DSS, Inc.
ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by DSS, Inc. (NYSE American: DSS), please note that in paragraph fourteen, [With more...
DSS Announces Letter to Shareholders
28 févr. 2022 08h00 HE
|
DSS, Inc.
ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with ten operating business lines in diverse, high-growth...
DSS to Present at Aegis Virtual Conference
22 févr. 2022 17h00 HE
|
DSS, Inc.
ROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
DSS Receives $17 Million Investment from Alset EHome International
25 janv. 2022 16h30 HE
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
DSS Acquires 25.1% of Alset International Limited
19 janv. 2022 12h13 HE
|
DSS, Inc.
DSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS ROCHESTER, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE)...
DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building
12 janv. 2022 08h30 HE
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
Impact BioMedical Announces New Bioplastics Test Results
11 janv. 2022 10h00 HE
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS) along with its scientific research partner Global Research and...
DSS Retains Leading Blockchain and Digital Assets Law Firm to Accelerate Launch of Digital Asset Exchange
10 janv. 2022 08h30 HE
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
DSS Provides Update on Expansion of Premier Packaging Subsidiary
22 déc. 2021 07h30 HE
|
DSS, Inc.
ROCHESTER, N.Y., Dec. 22, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...